Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internat…
Biotechnology
US, Novato [HQ]
Balance Sheet
13 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | 12.00 | 88.00 | 59.00 | 197.00 | 559.00 | 540.00 | 490.00 | 719.00 | 1,135.00 | 1,759.00 | 1,522.00 | 1,545.00 | 1,491.00 | |
|
Current
|
10.00 | 86.00 | 55.00 | 187.00 | 450.00 | 498.00 | 244.00 | 522.00 | 851.00 | 1,295.00 | 856.00 | 883.00 | 732.00 | |
| Cash And Equivalents | 10.00 | 86.00 | 7.00 | 24.00 | 93.00 | 161.00 | 100.00 | 113.00 | 433.00 | 713.00 | 307.00 | 132.00 | 213.00 | |
| Assets | 12.00 | 88.00 | 59.00 | 197.00 | 559.00 | 540.00 | 490.00 | 719.00 | 1,135.00 | 1,759.00 | 1,522.00 | 1,545.00 | 1,491.00 | |
| Accounts Receivables (AR) | - - | - - | - - | - - | - - | - - | -5.00 | -7.00 | -20.00 | 9.00 | -5.00 | -12.00 | -22.00 | |
| Inventory | - - | - - | - - | - - | - - | - - | - - | 7.00 | 11.00 | 13.00 | 16.00 | 26.00 | 33.00 | |
| Short Term Investments | - - | - - | 45.00 | 163.00 | 343.00 | 219.00 | 134.00 | 346.00 | 321.00 | 488.00 | 432.00 | 614.00 | 363.00 | |
| Other Current Assets | - - | - - | 1.00 | 5.00 | 13.00 | 21.00 | 29.00 | 42.00 | 46.00 | 47.00 | -187.00 | 68.00 | -777.00 | |
|
Non Current
|
1.00 | 1.00 | 4.00 | 10.00 | 109.00 | 42.00 | 246.00 | 197.00 | 284.00 | 464.00 | 665.00 | 661.00 | 758.00 | |
| Property, Plant, Equipment (Net) | - - | 1.00 | 1.00 | 3.00 | 7.00 | 17.00 | 21.00 | 20.00 | 74.00 | 114.00 | 176.00 | 285.00 | 290.00 | |
|
Intangible Assets
|
- - | - - | - - | - - | - - | - - | 141.00 | 129.00 | 129.00 | 131.00 | 130.00 | 160.00 | 166.00 | |
| Goodwill | - - | - - | - - | - - | - - | - - | 44.00 | 44.00 | 44.00 | 44.00 | 44.00 | 44.00 | 44.00 | |
| Long Term Investments | - - | - - | - - | - - | 99.00 | 117.00 | 9.00 | - - | 32.00 | 165.00 | 293.00 | 154.00 | 199.00 | |
| Other Non Current Assets | - - | - - | 3.00 | 7.00 | 2.00 | -92.00 | 3.00 | 3.00 | -4.00 | -24.00 | 11.00 | 10.00 | 51.00 | |
| Liabilities | 1.00 | 3.00 | 9.00 | 13.00 | 28.00 | 66.00 | 107.00 | 110.00 | 481.00 | 605.00 | 599.00 | 1,192.00 | 1,215.00 | |
|
Current
|
- - | 3.00 | 5.00 | 12.00 | 27.00 | 60.00 | 71.00 | 74.00 | 103.00 | 189.00 | 181.00 | 261.00 | 280.00 | |
| Accounts Payable | - - | - - | - - | 3.00 | -1.00 | 2.00 | 3.00 | 3.00 | 20.00 | 29.00 | 2.00 | 87.00 | 2.00 | |
| Short Term Debt | - - | - - | - - | - - | - - | - - | - - | - - | 7.00 | 8.00 | 11.00 | 11.00 | 12.00 | |
| Deferred Revenue | - - | - - | - - | - - | - - | - - | 5.00 | - - | - - | 59.00 | 7.00 | 1.00 | 196.00 | |
| Tax Payable | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Current Liabilities | - - | 1.00 | 4.00 | 7.00 | 24.00 | 54.00 | 56.00 | 62.00 | 83.00 | 108.00 | 145.00 | 204.00 | 29.00 | |
|
Non Current
|
- - | - - | 3.00 | - - | - - | 6.00 | 36.00 | 35.00 | 378.00 | 415.00 | 418.00 | 931.00 | 935.00 | |
| Long Term Debt | - - | - - | - - | - - | - - | - - | - - | - - | 29.00 | 39.00 | 30.00 | 19.00 | 30.00 | |
| Leasing Obligations | - - | - - | - - | - - | - - | - - | - - | - - | 36.00 | 48.00 | 41.00 | 31.00 | 43.00 | |
| Deferred Non Current Tax Liabilities | - - | - - | - - | - - | - - | - - | 31.00 | 31.00 | 33.00 | 33.00 | 33.00 | 31.00 | 30.00 | |
| Other Non Current Liabilities | - - | - - | 3.00 | - - | - - | 6.00 | 5.00 | 4.00 | 315.00 | 335.00 | 352.00 | 880.00 | 12.00 | |
| Equity | 10.00 | 84.00 | 50.00 | 184.00 | 531.00 | 473.00 | 383.00 | 608.00 | 653.00 | 1,154.00 | 922.00 | 352.00 | 275.00 | |
| Stockholders' Equity | 10.00 | 84.00 | 50.00 | 184.00 | 531.00 | 473.00 | 383.00 | 608.00 | 653.00 | 1,154.00 | 922.00 | 352.00 | 275.00 | |
| Retained Earnings | -8.00 | -27.00 | -74.00 | -139.00 | -284.00 | -530.00 | -832.00 | -1,030.00 | -1,433.00 | -1,619.00 | -2,073.00 | -2,781.00 | -3,387.00 | |
| Common Stock | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Preferred Stock | 18.00 | 111.00 | 124.00 | 197.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Profit | -6.00 | -16.00 | -35.00 | -59.00 | -145.00 | -245.00 | -302.00 | -197.00 | -402.00 | -186.00 | -454.00 | -707.00 | -606.00 | |
| Dividends | - - | - - | - - | -4.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Minority Interest | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Stockholders' Equity | - - | - - | - - | 126.00 | 816.00 | 1,003.00 | 1,222.00 | 1,639.00 | 2,086.00 | 2,773.00 | 2,997.00 | 3,140.00 | 3,662.00 | |
| Loss Other Compr. Income | - - | - - | - - | - - | - - | - - | -5.00 | - - | - - | - - | -1.00 | -6.00 | - - |